EMD
EMD (emerin) is a serine-rich nuclear membrane protein of the nuclear lamina-associated protein family, where it anchors the membrane to the cytoskeleton. It is also known as STA or LEMD5, and the gene was previously named Emery-Dreifuss muscular dystrophy. Browse Assay Genie's current range of EMD research reagents below, or read on for the biology behind the target.
EMD is a nuclear envelope protein that links the nuclear membrane to the cytoskeleton. It stabilises and promotes the formation of a nuclear actin cortical network, and in vitro it stimulates actin polymerisation by binding and stabilising the pointed end of growing filaments. It also links centrosomes to the nuclear envelope through an association with microtubules, and it is required for the proper localisation of non-farnesylated prelamin-A/C. Together with NEMP1, emerin contributes to nuclear envelope stiffness in germ cells.
Emerin also acts as a regulator of signalling. It inhibits beta-catenin activity by preventing its accumulation in the nucleus, influencing nuclear beta-catenin levels through a CRM1-dependent export pathway. In the context of viral infection, EMD and BAF are cooperative cofactors of HIV-1 infection: association of EMD with viral DNA requires BAF and viral integrase, and association of viral DNA with chromatin requires both BAF and EMD.
The EMD gene is a member of the HGNC group of LEM domain containing proteins, and the protein localises to the inner and outer membranes of the nucleus. Mouse and rat orthologs are both designated Emd. The gene was formerly named Emery-Dreifuss muscular dystrophy, reflecting its disease association: Dreifuss-Emery muscular dystrophy is an X-linked inherited degenerative myopathy that results from mutation in the emerin gene. Researchers studying EMD often work on nuclear mechanics, lamina biology and the cytoskeletal connections of the nucleus.
Mutation in the emerin gene causes X-linked Dreifuss-Emery muscular dystrophy, a degenerative myopathy, making EMD a central target in this field.
Emerin sits in the nuclear membrane, anchors it to the cytoskeleton and helps localise prelamin-A/C, so it is studied in nuclear architecture.
EMD promotes a nuclear actin cortical network, links centrosomes to the envelope and contributes to nuclear envelope stiffness in germ cells.
Emerin limits nuclear beta-catenin accumulation and, with BAF, acts as a cofactor in HIV-1 infection, linking it to signalling and virus studies.
EMD (emerin) anchors the nuclear membrane to the cytoskeleton. It stabilises a nuclear actin cortical network, stimulates actin polymerisation in vitro, links centrosomes to the nuclear envelope and keeps beta-catenin from accumulating in the nucleus through a CRM1-dependent export pathway.
The HGNC-approved symbol is EMD and the full name is emerin. Aliases include STA and LEMD5, and the gene was previously named Emery-Dreifuss muscular dystrophy. HGNC places it in the LEM domain containing gene group. The mouse and rat orthologs are both called Emd.
Mutation in the emerin gene, located on the X chromosome, results in Dreifuss-Emery muscular dystrophy, an X-linked inherited degenerative myopathy. EMD is also reported as a cooperative cofactor with BAF in HIV-1 infection, where it associates with viral DNA.
Other LEM domain proteins, nuclear lamina components and binding partners of emerin with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P50402; product specifications from Assay Genie datasheets.